Gilead Sciences (GILD) has internally discussed potential split up - Bloomberg, citing EVP
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Gilead Sciences (NASDAQ: GILD) EVP of R&D said the company has discussed splitting-up internally, according to Bloomberg. Splitting up is not high on the list of the company's priorities, the executive said.
Gilead is always active in M&A, but not desperate. The company is open to all options, but would look for something sensible, according to today's commentary.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Acacia Communications (ACIA) Mentioned as Short in Lakewood Capital's Q3 Letter - Bloomberg
- Apple (AAPL) February weekly volatility at 29 into Q1 and outlook
- GlobalStar (GSAT) Announces Departure of COO David Kagan
Create E-mail Alert Related CategoriesManagement Comments, Spinoffs, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!